Michele Bartoletti

10.7k total citations · 1 hit paper
123 papers, 3.4k citations indexed

About

Michele Bartoletti is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Michele Bartoletti has authored 123 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 50 papers in Infectious Diseases and 34 papers in Molecular Medicine. Recurrent topics in Michele Bartoletti's work include Antibiotic Resistance in Bacteria (34 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers) and Antibiotic Use and Resistance (21 papers). Michele Bartoletti is often cited by papers focused on Antibiotic Resistance in Bacteria (34 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers) and Antibiotic Use and Resistance (21 papers). Michele Bartoletti collaborates with scholars based in Italy, Spain and United States. Michele Bartoletti's co-authors include Pierluigi Viale, Maddalena Giannella, Sara Tedeschi, Russell E. Lewis, Simone Ambretti, Paolo Gaibani, Linda Bussini, Fabio Tumietto, Francesco Cristini and Renato Pascale and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Hepatology.

In The Last Decade

Michele Bartoletti

114 papers receiving 3.4k citations

Hit Papers

Infections caused by KPC-producing Klebsiella pneumoniae ... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Bartoletti Italy 35 1.5k 1.4k 902 833 754 123 3.4k
Emanuele Durante‐Mangoni Italy 35 2.3k 1.6× 1.2k 0.8× 1.2k 1.4× 724 0.9× 378 0.5× 145 4.3k
Sara Tedeschi Italy 26 1.1k 0.7× 1.8k 1.3× 606 0.7× 1.1k 1.3× 791 1.0× 81 3.0k
Maddalena Giannella Italy 41 2.3k 1.6× 2.4k 1.7× 1.5k 1.6× 1.5k 1.8× 1.2k 1.5× 217 5.5k
Manuel Almela Spain 24 2.2k 1.5× 755 0.5× 886 1.0× 412 0.5× 420 0.6× 51 3.5k
Marco Falcone Italy 44 2.6k 1.8× 2.0k 1.4× 2.0k 2.2× 1.2k 1.4× 1.1k 1.4× 235 6.2k
Francesco Cristini Italy 26 925 0.6× 1.1k 0.8× 831 0.9× 941 1.1× 472 0.6× 59 2.5k
Gopi Patel United States 24 1.1k 0.7× 1.5k 1.1× 687 0.8× 653 0.8× 409 0.5× 81 2.7k
Valerio Del Bono Italy 32 1.4k 0.9× 1.0k 0.7× 962 1.1× 639 0.8× 481 0.6× 80 2.8k
Simone Ambretti Italy 34 1.6k 1.1× 2.8k 2.0× 586 0.6× 1.4k 1.7× 946 1.3× 146 4.3k
Leanne B. Gasink United States 20 868 0.6× 1.5k 1.0× 315 0.3× 965 1.2× 711 0.9× 47 2.4k

Countries citing papers authored by Michele Bartoletti

Since Specialization
Citations

This map shows the geographic impact of Michele Bartoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bartoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bartoletti more than expected).

Fields of papers citing papers by Michele Bartoletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bartoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bartoletti. The network helps show where Michele Bartoletti may publish in the future.

Co-authorship network of co-authors of Michele Bartoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Bartoletti. A scholar is included among the top collaborators of Michele Bartoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Bartoletti. Michele Bartoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marzano, Angelo Valerio, Michele Bartoletti, Vincenzo Bettoli, et al.. (2025). Hidradenitis suppurativa, from basic science to surgery and a new era of tailored targeted therapy: An expert opinion paper. Archives of Dermatological Research. 317(1). 511–511. 1 indexed citations
2.
Bella, Stefano Di, Bruna Marini, Giacomo Stroffolini, et al.. (2025). The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implications. European Journal of Clinical Microbiology & Infectious Diseases. 44(8). 1797–1816. 5 indexed citations
3.
Clemente, Nicolò, Fabiola Giudici, Luca Martella, et al.. (2025). Recurrence patterns and prognostic factors in vulvar extramammary Paget’s disease: a 10-year single institution experience. International Journal of Gynecological Cancer. 35(12). 102724–102724.
4.
Ricci, Elena, Matteo Faltoni, Giordano Madeddu, et al.. (2024). Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections. Journal of Global Antimicrobial Resistance. 39. 4–4.
5.
Mozaffari, Essy, Michele Bartoletti, Jakob J Malin, et al.. (2024). Evolution of the Evidence for the Management of COVID-19 in Hematologic Malignancies: A Systematic Literature Review of Remdesivir. Blood. 144(Supplement 1). 7750–7750.
6.
Mauro, Francesca Romana, Anna Maria Frustaci, Andrea Visentin, et al.. (2024). Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors. Critical Reviews in Oncology/Hematology. 201. 104408–104408. 1 indexed citations
7.
Kalil, André C., Aastha Chandak, Luke Moore, et al.. (2024). Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19. Clinical Infectious Diseases. 79(Supplement_4). S160–S166.
8.
Vena, Antonio, Matteo Bassetti, Francesco Marchesi, et al.. (2023). Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape. Infection. 52(1). 197–208. 9 indexed citations
9.
Bartoletti, Michele, Linda Bussini, Davide Fiore Bavaro, & Valeria Cento. (2023). What do clinicians mean by epidemics' preparedness. Clinical Microbiology and Infection. 30(5). 586–591. 1 indexed citations
10.
Amati, Francesco, Anna Stainer, Andrea Gramegna, et al.. (2023). Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia. Advances in respiratory medicine. 91(3). 224–238. 8 indexed citations
11.
Viciani, Elisa, Paolo Gaibani, Andrea Castagnetti, et al.. (2022). Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.. International Journal of Infectious Diseases. 117. 233–240. 14 indexed citations
12.
Gaibani, Paolo, Linda Bussini, Michele Bartoletti, et al.. (2022). Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient. Microorganisms. 10(4). 778–778. 10 indexed citations
13.
Freire, Maristela Pinheiro, Matteo Rinaldi, Débora Raquel Benedita Terrabuio, et al.. (2022). Prediction models for carbapenem‐resistant Enterobacterales carriage at liver transplantation: A multicenter retrospective study. Transplant Infectious Disease. 24(6). e13920–e13920. 10 indexed citations
14.
Giampieri, Enrico, Francesca Coppola, Federica Ciccarese, et al.. (2022). Outcome Prediction for SARS-CoV-2 Patients Using Machine Learning Modeling of Clinical, Radiological, and Radiomic Features Derived from Chest CT Images. Applied Sciences. 12(9). 4493–4493. 5 indexed citations
15.
Gaibani, Paolo, Donatella Lombardo, Linda Bussini, et al.. (2021). Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018. Antibiotics. 10(5). 536–536. 38 indexed citations
16.
Coppola, Francesca, Enrico Giampieri, Giulio Vara, et al.. (2021). Classification Performance for COVID Patient Prognosis from Automatic AI Segmentation—A Single-Center Study. Applied Sciences. 11(12). 5438–5438. 5 indexed citations
17.
Baldassarre, Maurizio, Marina Naldi, Giacomo Zaccherini, et al.. (2021). Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications. Hepatology. 74(4). 2058–2073. 50 indexed citations
18.
Londero, Francesco, Orlando Parise, Angelo Morelli, et al.. (2020). The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal Cancer. Journal of Clinical Medicine. 9(11). 3566–3566. 2 indexed citations
19.
Tumbarello, Mario, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa, et al.. (2015). Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study. Journal of Antimicrobial Chemotherapy. 70(7). 2133–2143. 395 indexed citations breakdown →
20.
Girometti, Nicolò, Russell E. Lewis, Maddalena Giannella, et al.. (2014). Klebsiella pneumoniae Bloodstream Infection. Medicine. 93(17). 298–309. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026